Overexpression of c-erbB-2 is related to a higher expression of vascular endothelial growth factor (VEGF) and constitutes an independent prognostic factor in primary node-positive breast cancer after adjuvant systemic treatment

By Linderholm B.   Andersson J.   Lindh B.   Beckman L.   Erlanson M.   Edin K.   Tavelin B.   Grankvist K.   Henriksson R.  

European Journal of Cancer, Vol. 40, Iss. 1, 2004-01 ,pp. : 33-42

Elsevier

Access to resources Recommend Favorite

Expression of midkine and vascular endothelial growth factor in gastric cancer and the association of high levels with poor prognosis and survival

By      

Molecular Medicine Reports, Vol. 5, Iss. 2, 2012-01 ,pp. : 415-419

Spandidos Publications

Access to resources Recommend Favorite

Association between the expression of T-cadherin and vascular endothelial growth factor and the prognosis of patients with gastric cancer

By            

Molecular Medicine Reports, Vol. 12, Iss. 2, 2015-01 ,pp. : 2075-2081

Spandidos Publications

Access to resources Recommend Favorite

Digoxin use and risk of invasive breast cancer: evidence from the Nurses’ Health Study and meta-analysis

By Ahern Thomas   Tamimi Rulla   Rosner Bernard   Hankinson Susan  

Breast Cancer Research and Treatment, Vol. 144, Iss. 2, 2014-04 ,pp. : 427-435

Springer Publishing Company

Access to resources Recommend Favorite

Vascular endothelial growth factor receptor 2 and downstream p38 mitogen-activated protein kinase are possible candidate markers of intrinsic resistance to adjuvant endocrine treatment in steroid receptor positive breast cancer

By Linderholm Barbro  

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 457-465

Springer Publishing Company

Access to resources Recommend Favorite